Connor, Clark & Lunn Investment Management (CC&L)
IRWD icon

Connor, Clark & Lunn Investment Management (CC&L)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.63M Sell
1,811,714
-23,710
-1% -$91.4K 0.01% 615
2026
Q1 		$6.44M Sell
1,835,424
-155,503
-8% -$637K 0.01% 612
2025
Q4 		$6.71M Sell
1,990,927
-170,891
-8% -$444K 0.02% 568
2025
Q3 		$2.83M Sell
2,161,818
-45,130
-2% -$46.7K 0.01% 747
2025
Q2 		$1.58M Buy
2,206,948
+718,904
+48% +$564K 0.01% 926
2025
Q1 		$2.19M Buy
1,488,044
+1,146,589
+336% +$2.73M 0.01% 706
2024
Q4 		$1.51M Buy
341,455
+215,166
+170% +$873K 0.01% 804
2024
Q3 		$520K Buy
126,289
+75,917
+151% +$408K ﹤0.01% 1088
2024
Q2 		$328K Buy
+50,372
New +$356K ﹤0.01% 1160
2024
Q1 		– Sell
-303,675
Closed -$3.47M – 1612
2023
Q4 		$3.47M Sell
303,675
-197,006
-39% -$1.95M 0.02% 525
2023
Q3 		$4.82M Sell
500,681
-136
-0% -$1.33K 0.03% 409
2023
Q2 		$5.33M Buy
500,817
+8,293
+2% +$89.1K 0.03% 385
2023
Q1 		$5.18M Buy
492,524
+189,959
+63% +$2.13M 0.03% 361
2022
Q4 		$3.75M Buy
+302,565
New +$3.43M 0.02% 415
2019
Q4 		– Sell
-59,175
Closed -$508K – 1011
2019
Q3 		$508K Buy
+59,175
New +$575K ﹤0.01% 677
2016
Q1 		– Sell
-48,238
Closed -$468K – 870
2015
Q4 		$468K Buy
48,238
+1,433
+3% +$13.8K ﹤0.01% 553
2015
Q3 		$408K Buy
+46,805
New +$437K ﹤0.01% 556

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Connor, Clark & Lunn Investment Management (CC&L)'s IRWD Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) reduced its Ironwood Pharmaceuticals (IRWD) stake by 1.3% in Q2 2026, selling an estimated $91.4K and leaving 1,811,714 shares worth $7.63M. The position accounts for 0.01% of the portfolio, ranked #615.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in IRWD in Q3 2015 and has held it in 17 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 1,811,714 shares of Ironwood Pharmaceuticals worth $7.63M as of Q2 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 23,710 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $91.4K.
  • Ironwood Pharmaceuticals made up 0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #615 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Ironwood Pharmaceuticals in Q3 2015 and has held it in 17 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.